Therapy
ISSN 2412-4036 (Print)
ISSN 2713-1823 (Online)
Menu
Archives
Home
About the Journal
Editorial Team
Editorial Policies
Author Guidelines
About the Journal
Issues
Search
Current
Retracted articles
Archives
Contact
Subscriptions
Editorial Board
All Journals
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
SARS-CoV-2
arterial hypertension
atrial fibrillation
bronchial asthma
cardiovascular diseases
cardiovascular risk
chronic heart failure
chronic kidney disease
chronic obstructive pulmonary disease
comorbidity
coronary heart disease
diabetes mellitus
heart failure
myocardial infarction
non-alcoholic fatty liver disease
obesity
osteoarthritis
rheumatoid arthritis
risk factors
type 2 diabetes mellitus
×
User
Username
Password
Remember me
Forgot password?
Register
Notifications
View
Subscribe
Subscription
Login to verify subscription
Search
Search
Search Scope
All
Authors
Title
Abstract
Index terms
Full Text
Browse
By Issue
By Author
By Title
Other Journals
Categories
Keywords
COVID-19
SARS-CoV-2
arterial hypertension
atrial fibrillation
bronchial asthma
cardiovascular diseases
cardiovascular risk
chronic heart failure
chronic kidney disease
chronic obstructive pulmonary disease
comorbidity
coronary heart disease
diabetes mellitus
heart failure
myocardial infarction
non-alcoholic fatty liver disease
obesity
osteoarthritis
rheumatoid arthritis
risk factors
type 2 diabetes mellitus
Home
>
Search
>
Author Details
Author Details
Токмачев, Роман Евгеньевич
Issue
Section
Title
File
Vol 9, No 1 (2023)
ORIGINAL STUDIES
Soluble suppression of tumorigenicity 2 (sST2) as a predictor of adverse outcomes of chronic heart failure
TOP
